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Staphylococcus aureus and Pseudomonas aeruginosa are major pathogens in chronic rhi-
nosinusitis (CRS) and their biofilms have been associated with poorer postsurgical out-
comes. This study investigated the distribution and anti-biofilm effect of cationic (+) and
anionic (-) phospholipid liposomes with different sizes (unilamellar and multilamellar vesicle,
ULV and MLV respectively) on S. aureus and P. aeruginosa biofilms.
Method
Specific biofilm models for S. aureus ATCC 25923 and P. aeruginosa ATCC 15692 were
established. Liposomal distribution was determined by observing SYTO9 stained biofilm
exposed to DiI labeled liposomes using confocal scanning laser microscopy, followed by
quantitative image analysis. The anti-biofilm efficacy study was carried out by using the
alamarBlue assay to test the relative viability of biofilm treated with various liposomes for
24 hours and five minutes.
Results
The smaller ULVs penetrated better than larger MLVs in both S. aureus and P. aeruginosa
biofilm. Except that +ULV and –ULV displayed similar distribution in S. aureus biofilm, the
cationic liposomes adhered better than their anionic counterparts. Biofilm growth was inhib-
ited at 24-hour and five-minute exposure time, although the decrease of viability for P. aeru-
ginosa biofilm after liposomal treatment did not reach statistical significance.
Conclusion
The distribution and anti-biofilm effects of cationic and anionic liposomes of different
sizes differed in S. aureus and P. aeruginosa biofilms. Reducing the liposome size and
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formulating liposomes as positively charged enhanced the penetration and inhibition of S.
aureus and P. aeruginosa biofilms.
Introduction
Both Staphylococcus aureus and Pseudomonas aeruginosa are major pathogens causing com-
munity-acquired and nosocomial infections all over the world. In the field of rhinology, evi-
dence from molecular diagnostics in a recent microbiome study demonstrated that the
prevalence of S. aureus and P. aeruginosa in patients of chronic rhinosinusitis (CRS) was 61%
and 8% respectively[1].
Bacterial biofilms are highly organized structures consisting of bacterial communities and
extracellular matrix[2]. Their presence in CRS patients has been associated with decreased
quality of life, greater mucosal inflammation, more severe osteitis and higher incidence of
recurrent infection[2–5]. In particular, amongst the most frequently isolated pathogens from
nasal mucosa of CRS patients, S. aureus biofilm plays a predominant role in negatively influ-
encing postoperative outcomes[6]and P. aeruginosa biofilm has been linked to poorer postsur-
gical progression as well[7].
When biofilm is formed, bacteria become up to 1000 times more resistant to antibiotic treat-
ment compared to the planktonic type, which makes eradication even more challenging[8, 9].
It has been proven that liposome-encapsulation improves the efficacy of various antibacterial
and antifungal drugs against a broad range of pathogens in vitro and in vivo[10–15], by more
effective drug delivery. Due to their biocompatibility, liposomes formulated by ubiquitous and
nontoxic lipid-like molecules are promising in preventing biofilm formation and removing
existing biofilm[16–18]. Based on an increasing number of studies on the interaction between
liposomes and biofilms, the size and charge of the liposome are considered as important
factors influencing penetration[18–20]. Depending on the bacteria species the heterogeneous
composition of biofilm matrix and the cell membranes could also affect the interaction between
bacteria and liposomes as well as their therapeutic efficacy[21]. To date, how the liposomal
properties such as the charge, size and structure influence this interaction, and how this corre-
lates with the anti-biofilm efficacy is not fully understood.
The goal of this study was to investigate the distribution and anti-biofilm effects of cationic
and anionic liposomes with various sizes on S. aureus and P. aeruginosa biofilm in vitro. To
this end we prepared a library of phospholipid liposomes and determined the liposome-biofilm
interaction using confocal scanning laser microscopy (CSLM). The viability of biofilms after
liposomal intervention was determined using the alamarBlue assay.
Materials and Methods
Liposome Preparation
Based on the well-documented liposome preparation method originated by Bangham et al[22,
23], the multilamellar vesicles (MLV) and unilamellar vesicles (ULV) were produced as follows:
1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and 1,2-dipalmitoyl-sn-glycero-3-phos-
phoglycerol sodium salt (DPPG) were obtained from Lipoid (Lipoid GmbH, Ludwigshafen,
Germany). 1,2-dioleyl-3-trimethylammonium-propane (DOTAP) was purchased from Avanti
Polar Lipids (Montgomery, AL, USA). 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine
perchlorate (DiI), chloroform, and methanol were purchased from Sigma (Sigma-Aldrich, Syd-
ney, Australia). All solvents were of analytical grade and were used as received.
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The liposomes were prepared by the lipid-film hydration method described previously[8,
24]. Briefly, phospholipids (DSCP/DPPG and DSCP/DOTAP) were used in a 4:1 molar ratio
for the preparation of anionic and cationic liposomes, respectively. The phospholipids were
dissolved in 10 mL of a mixture of chloroform/ methanol (90: 10%, vol/vol) in a 50 mL round
bottom flask. The organic solvent was removed overnight under vacuum on a rotavapor
(Buechi Labortechnik, Flawil Switzerland). The resulting dry lipid film was then rehydrated for
2 hours with 10 ml of a sterile physiological saline solution to produce a liposome dispersion
consisting of MLV. ULVs were prepared fromMLV dispersions via extrusion using a thermo
extruder (Northern Lipids, Burnaby, BC, Canada) at 60°C (i.e. 5°C above the transition tem-
perature of DSPC). The liposome dispersions were subjected to ten consecutive extrusion
cycles through two stacked polycarbonate membranes (Millipore, Billerica, MA, USA) with a
pore size of 1000 nm, followed by another ten consecutive extrusion cycles using two stacked
membranes of 200 nm pore-size. The final lipid concentration of the MLV and ULV dispersion
was 25 mM. An analogous protocol[25, 26] was employed for the preparation of fluorescently
labeled liposomes for the confocal microscopy studies by addition 0.2% (w/w) of the lipophilic
membrane stain DiI to the organic solvent/lipid mixture.
Liposome Characterization
The MLV and ULV dispersions were characterised for particle size, particle size distribution,
and zeta-potential by dynamic light scattering (DLS) and phase analysis light scattering
(PALS) at 37°C using a Zetasizer Nano-ZS particle sizer (Malvern, Worcestershire, UK).
Dynamic light scattering follows the time-dependent fluctuation of the Rayleigh scattering of
dispersed particles resulting from Brownian motion. Application of the Mie theory and Stokes-
Einstein equation allows the calculation of the particle size and the width of the size distribu-
tion from the time-autocorrelation function. Phase analysis light scattering is based on the
Smoluchowski/ Huckel theories using the electrophoretic mobility of the particles (i.e. the ratio
of the velocity of particles to the field strength) to compute the mean zeta potential. Samples
were prepared by Dilution of 0.1 mL of the dispersions with 0.9 mL of Milli-Q water. All mea-
surements were carried out in triplicates and the results are reported as the mean ± standard
deviation.
Bacterial Strains and Biofilm Formation
The known biofilm forming strains S. aureus American Type Culture Collection (ATCC)
25923 and P. aeruginosa ATCC 15692 were used in the current study. The bacterial cultures
for both of the strains were established as previously published[8]with modifications. Briefly,
bacterial strains from the frozen glycerol stock were streaked on the nutrient agar (Oxoid, SA,
Australia) plate and incubated at 37°C overnight to revive. Then bacterial suspension of 1
McFarland unit in 0.9% saline was adjusted with single colonies from the plate culture above.
The suspension was then diluted to 1:15 in CSF broth (Thermo Fisher, SA, Australia) to be
used in the formation of biofilms.
Different biofilm models were established for the liposomal distribution and anti-biofilm
studies separately with optimized growth conditions. To observe the distribution of liposomes
in biofilm using CSLM, 8-well culture slides (BD Falcon, NSW, Australia) were used. For S.
aureus biofilm formation, 300μl of the bacterial suspension was added to each well and incu-
bated at 37°C on the gyrorotary shaker (Ratek, Vic, Australia) at 70rpm. After 24-hour incuba-
tion, all the media was gently replaced by fresh CSF broth to maintain bacterial viability, and
then followed by another 48-hour incubation at 37°C with 5% CO2 and 90% humidity to allow
further biofilm formation. For P. aeruginosa, the culture slide was adjusted to sit at 45° angle
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from horizontal with 150μl of the aforementioned bacterial suspension in each well for biofilm
formation at the air-liquid interface[27]. After 24-hour incubation at 37°C statically, 50μl
media was carefully replaced and then followed by another 48-hour culture in the same condi-
tion as for the S. aureus biofilm.
For the liposomal anti-biofilm experiments, the method of Kien[9] and Jardeleza[8] was
used with the only modification that 150μl of S. aureus or P. aeruginosa dilution was pipetted
into the wells of the 96 well clear-bottom microplates (Corning Life Sciences Plastic, NY, USA)
and incubated for 48 hours at 37°C on the gyrorotary shaker at 70rpm for biofilm growth.
Liposomal Distribution Study
The liposomal distribution study was conducted within 20 hours after the DiI-labelled lipo-
somes were prepared. The bacterial biofilm on the culture slide was rinsed twice with saline
(0.9% NaCl) to remove the planktonic cells[19, 28] and then incubated with 300μL/well of the
DiI-labelled liposomes for five minutes. Saline was applied as the non-treatment control. Sub-
sequently, the samples were fixed with 300μL/well of 5% glutaraldehyde (Sigma Aldrich, St
Louis, MO, USA) for 30 minutes at room temperature prior to staining. Then 300μL/well of
5μM SYTO9 (Invitrogen Molecular Probes, Vic, Australia) solution in saline was inoculated to
each well and incubated in the dark for 15 minutes at room temperature to label the cells.
Every single step was followed by two saline rinses. After removing the upper chamber of the
culture slide, the samples were sealed with glycerol (Sigma-Aldrich, Sydney, Australia) and
ready to be examined under the confocal scanning laser microscope. For S. aureus biofilm, the
Leica TCS SP5 (Leica Microsystems, Wetzlar, Germany) was employed with the settings as fol-
lows: 63×/1.2 objective and 0.5μm for laser scanning step size. Fluorescence from DiI was
detected using the excitation wavelength of 561 nm and emission of 570–600 nm; fluorescence
from SYTO9 was excited at 476 nm and collected at 500–520 nm. The P. aeruginosa biofilm
study was carried out using a Zeiss LSM700 confocal scanning laser microscope (Carl Zeiss
Microscopy GmbH, Oberkochen, Germany), where the settings were adjusted slightly due to
the different hardware: 63×/1.4 objective, and the excitation/ emission wavelength for DiI and
SYTO9 was 555nm/ 570nm~ and 488nm/ ~520nm respectively. For each sample, three repre-
sentative z-stacks containing the full thickness of biofilm with liposomes were captured and
experiments were repeated twice. The image processing and analysis were carried out by the
software ZEN (ZEISS Microscope Software 2012) and ImageJ 1.43 (Wayne Rasband, National
Institutes of Health, Bethesda, MD, USA).
Liposomal Anti-biofilm Study
The liposomal anti-biofilm study was conducted within 20 hours after the liposomes were pre-
pared. The prepared biofilm-coated wells of the 96-well microtiter plate were rinsed twice in
saline to remove planktonic bacteria and then exposed to 200μL liposome dispersion for five
minutes and 24 hours at 37°C followed by another two washes. After treatment, 200μL CSF
broth was pipetted to each well and incubated at 37°C for 24 hours to allow the biofilm recov-
ery with adhered liposomes[8]. Subsequently, after the effect of liposomes to alamarBlue
(Invitrogen, CA, USA) was confirmed as negligible (S1 Fig), the alamarBlue assay (Invitrogen,
CA, USA) was performed to test the viability of challenged biofilm. According to the manufac-
turer’s instructions, the alamarBlue dye was diluted to 1:10 in CSF broth. After two rinses,
250μL/well of the alamarBlue dilution was added and incubated statically at 37°C for one hour.
Finally, the fluorescence intensity from the samples was measured by FLUOstar OPTIMA
plate reader (BMG Labtech, Vic, Australia) equipped with an excitation filter of 520–540 nm
and an emission filter of 580–600 nm. In our experiment, saline was used as the negative
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control for the liposomal treatment and the wells that did not contain biofilm were stained as
the background. All treatments were carried out in quadruplicate and the experiments repeated
twice.
Statistical Analysis
Kruskal-Wallis test with Mann-Whitney test for post-hoc comparisons was carried out by
Graphpad Prism 5.0 (San Diego, CA, USA) for analyzing differences among selected pairwise
treatment groups. A P value of< 0.05 was considered as statistically significant.
Results
Liposome Characterization
The particle size (reported as the intensity weighted z-average), particle size distribution
(reported as polydispersity index, PDI), and zeta-potential were summarized in Table 1. With-
out further processing the initially produced anionic and cationic MLV dispersions appeared
milky-white and showed high PDI (>0.6) which did not allow accurate size measurements of
the MLV dispersions by DLS. The extrusion of anionic and cationic MLV generated uniform
ULV of approximately 130–140 nm with a narrow particle size distribution (PDI0.1). As
expected, the inclusion of charged lipids (DPPG and DOTAP for anionic and cationic lipo-
somes, respectively) resulted in negative and positive zeta-potentials of the particles (absolute
zeta values of approximately 60–90 mV) indicating sufficient colloidal stability for all the pro-
duced dispersions for the duration of the study.
Liposomal Distribution
The formulations and bacteria were presented in red and green respectively, reflecting the
employed fluorescent dyes, DiI and SYTO9. Due to the differences of the microscopy settings
and the biofilm thickness, five layers in the centre of S. aureus biofilm from the entire z-stack
and two layers in the centre of P. aeruginosa biofilm were chosen as the representative pro-
jected images. The z-projections along with the cross-sections from the center of the x-stack
and y-stack exhibited different distributions of liposomes in biofilm (Fig 1 and Fig 2). For lipo-
somes in distinct sizes, the larger liposomes (+MLV and-MLV) appeared like clouds floating
above both S. aureus and P. aeruginosa biofilm. On the other hand, as expected, the smaller
liposomes (+ULV and-ULV) penetrated biofilm better than the corresponding larger ones (see
x- and y-stacks in Fig 1B and 1D and Fig 2B and 2D, depicting deep penetration of ULVs
within the biofilm, compared to x- and y-stacks in Fig 1A and 1C and Fig 2A and 2C, showing
MLVs in larger aggregations on top and around the biofilms). In terms of the liposome charge,
Table 1. Liposome characterization.
Liposome formulation Size (nm) PDI Zeta-potential (mV)
-MLV >1000 0.68 ± 0.26 -70.8 ± 2.3
-ULV 141.0 ± 1.3 0.09 ± 0.01 -56.6 ± 0.8
+MLV >1000 >0.86 +89.1± 4.2
+ULV 128.6 ± 2.3 0.12 ± 0.02 +58.6 ± 1.3
Data are expressed as mean ± SD, n = 3.
PDI = polydispersity index;-MLV = anionic multilamellar vesicle;-ULV = anionic unilamellar vesicle; +MLV = cationic multilamellar vesicle; +ULV = cationic
unilamellar vesicle.
doi:10.1371/journal.pone.0131806.t001
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more cationic liposomes (+MLV and +ULV) attached to P. aeruginosa biofilms compared with
their anionic counterparts (Fig 2A and 2B compared to Fig 2C and 2D). Also, after exposure
to +ULV, the appearance of P. aeruginosa biofilm was altered from a plateau-shaped structure
to a dispersed multi-laminar structure (see Fig 2B). The changes due to the different charges
were not as obvious in S. aureus biofilm as in P. aeruginosa biofilm.
In order to make a quantitative comparison for the distribution of the four different lipo-
somes in the biofilms, the integrated fluorescent density of every single layer in each z-stack
was measured separately for the red and green channel. The integrated fluorescent density of
the red channel was normalized by that of the green channel, as shown in Fig 3 and Fig 4,
reflecting the distribution of liposomes per unit of biomass in each layer from the surface to the
base of the biofilm. The mean thickness of S. aureus biofilm was 12μmwhile that of P. aerugi-
nosa biofilm was 6.5μm in the present study, so the normalized integrated fluorescent density
of the red channel was calculated on 24 and 13 layers in total to demonstrate the liposomal dis-
tribution in the entire z-stack for S. aureus and P. aeruginosa biofilm respectively. It was clear
that for both S. aureus and P. aeruginosa biofilm,–MLV did not associate strongly with the
body of the biofilms, and that +MLV was mainly found in the upper part of the biofilm struc-
ture. The distributions of ULVs in S. aureus biofilm were similar to each other. However,
+ULV displayed higher normalized fluorescent density in the whole z-stack of P. aeruginosa
biofilm than–ULV.
Fig 1. Orthogonal images from confocal laser scanningmicroscopy of S. aureus biofilm treated with
liposomes. Liposomes including A) cationic multilamellar vesicle (+MLV), B) cationic unilamellar vesicle
(+ULV), C) anionic multilamellar vesicle (-MLV) and D) anionic unilamellar vesicle (-ULV), were labeled red
(DiI) and biofilm was stained green (SYTO-9). The middle square image in the blue frame was the 3D
projection of five layers in the biofilm centre from the z-stack with the mode of maximum intensity, including
the layer with the maximum integrated fluorescent density of the green channel. The images on the top and
right side were the central layer from the y-stack and x-stack respectively. The scale bar represented 10μm.
doi:10.1371/journal.pone.0131806.g001
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After the values of integrated fluorescent density for both channels in the entire z-stack
were recorded, the layers with the maximum values were picked, representing the location
where the maximum amount of liposomes or biofilm biomass appeared (Maxred and
Maxgreen, respectively). Thus the following two parameters were designed to make further sta-
tistical comparison in our study: First, the Liposome Quantity, which was the integrated fluo-
rescent density of the red channel on the Maxgreen layer and normalized by it, reflecting the
distribution of liposomes per unit of biomass in the most intensive section (the “core” or the
centre) of the biofilm. Second, the Distance between the layer of Maxred and Maxgreen, repre-
senting the proximity of the majority of the liposomes to the core of the biofilm. Data were
summarized in Table 2 and Fig 5.
By determining the Liposome Quantity and the Distance, the interactions of the liposomes
with the biofilms were compared based on the liposomal size and charge. There was signifi-
cantly larger amounts of smaller liposomes adhering to both S. aureus (+MLV vs +ULV,
P = 0.0022;-MLV vs-ULV, P = 0.0022) and P. aeruginosa biofilm (+MLV vs +ULV, P =
0.0022;-MLV vs-ULV, P = 0.0022) than their larger counterparts with the same charge. The
smaller liposomes were also able to get significantly closer to the center of the biofilms
Fig 2. Orthogonal images from confocal laser scanningmicroscopy of P. aeruginosa biofilm treated
with liposomes. Liposomes including A) cationic multilamellar vesicle (+MLV), B) cationic unilamellar
vesicle (+ULV), C) anionic multilamellar vesicle (-MLV) and D) anionic unilamellar vesicle (-ULV), were
labeled red (DiI) and biofilm was stained green (SYTO-9). The middle square image in the blue frame was the
3D projection of two layers in the biofilm centre from the z-stack with the mode of maximum intensity,
including the layer with the maximum integrated fluorescent density of the green channel. The images on the
top and right side were the central layer from the y-stack and x-stack respectively. The scale bar represented
10μm.
doi:10.1371/journal.pone.0131806.g002
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(S. aureus, +MLV vs +ULV: P = 0.0047;-MLV vs-ULV, P = 0.0049; P. aeruginosa: +MLV vs
+ULV, P = 0.0086;-MLV vs-ULV, P = 0.0047). As to liposomes with opposite charges, +MLV
showed a significantly higher Liposome Quantity (S. aureus: P = 0.0022; P. aeruginosa:
P = 0.0022) and shorter Distance between Maxred and Maxgreen (S. aureus: P = 0.0047; P. aeru-
ginosa: P = 0.0045) than–MLV for biofilms of both strains. When +ULV and–ULV were com-
pared, there were no significant differences in either Liposome Quantity (P = 0.8182) or
Distance between Maxred and Maxgreen (P = 0.6191) in S. aureus biofilm. However, the amount
Fig 3. Liposomal distribution in S. aureus biofilm. The y-axis represents the integrated fluorescent
density of the red channel (liposomes) normalized by that of the green channel (biofilm), reflecting the amount
of liposomes per unit of biomass in each layer of the biofilm. The x-axis indicates the z-position of the layers in
biofilm, where the location of the top surface of biofilm was assigned as zero. +MLV: cationic multilamellar
vesicle; +ULV: cationic unilamellar vesicle;-MLV: anionic multilamellar vesicle;-ULV: anionic unilamellar
vesicle.
doi:10.1371/journal.pone.0131806.g003
Fig 4. Liposomal distribution in P. aeruginosa biofilm. The y-axis represents the integrated fluorescent
density of the red channel (liposomes) normalized by that of the green channel (biofilm), reflecting the amount
of liposomes per unit of biomass in each layer of the biofilm. The x-axis indicates the z-position of the layers in
biofilm, where the location of the top surface of biofilm was assigned as zero. +MLV: cationic multilamellar
vesicle; +ULV: cationic unilamellar vesicle;-MLV: anionic multilamellar vesicle;-ULV: anionic unilamellar
vesicle.
doi:10.1371/journal.pone.0131806.g004
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of +ULV co-localizing with P. aeruginosa biofilm was significantly greater than–ULV
(P = 0.0022), and the Distance between Maxred and Maxgreen for +ULV was shorter than–ULV,
although statistical significance was not reached (P = 0.5597).
Liposomal Anti-biofilm Effect
After normalization to the mean of fluorescent intensity for the control wells containing bio-
films without liposomal treatment, the result of biofilm relative viability was summarized in
Table 3 and Fig 6. The data demonstrated that after five-minute and 24-hour exposure, all
tested liposomes inhibited the growth of both S. aureus and P. aeruginosa biofilms. However,
the decrease in the viability of P. aeruginosa biofilm after five-minute treatment with the differ-
ent liposomes did not reach statistical significance. Post-hoc pairwise comparisons showed that
at 24-hour exposure, the cationic liposomes displayed significantly stronger anti-biofilm effect
than the anionic ones on P. aeruginosa biofilm (+MLV vs–MLV: P = 0.0052, +ULV vs–ULV:
P< 0.0001), and the smaller +ULV had stronger anti-biofilm effects than the larger +MLV
(P = 0.0249). Although the differences between liposomes against P. aeruginosa biofilm for five
minutes and against S. aureus biofilm for both five minutes and 24 hours had no statistical sig-
nificance (all P>0.05), there was a trend that the anti-biofilm effect of smaller liposomes was
stronger than the corresponding larger ones.
Discussion
The present study systematically investigated the distribution and anti-biofilm effects of lipo-
somes with opposite charges and different sizes on biofilms of the two important pathogens, S.
aureus and P. aeruginosa. Our data demonstrated that although the interaction between lipo-
somes and biofilms differed for each species of biofilm, the smaller and cationic liposomes pen-
etrated better and inhibited both biofilms.
Based on the nanotechnology in our study, the cationic liposomes were prepared in compa-
rable size to their anionic counterparts, which made it feasible to directly compare individual
liposomal property, i.e. size or charge, separately. The result from the liposomal distribution
study displayed that ULVs were able to reach to the centre of both S. aureus and P. aeruginosa
biofilms while MLVs with the same charge did not, suggesting that the size of the liposome
influenced penetration. According to the research on the penetration of liposomes and other
nanoparticles into Burkholderia multivorans and Pseudomonas aeruginosa biofilms, Forier
et al. also reported that the larger the particle diameter, the more the particles were excluded
Table 2. Distribution of liposomes in S. aureus and P. aeruginosa biofilm.
Liposome Quantity Distance
+MLV +ULV -MLV -ULV P
value


















































Data are expressed as median and range, n = 6.
All P values are determined with Kruskal-Wallis test.
+MLV = cationic multilamellar vesicle; +ULV = cationic unilamellar vesicle;-MLV = anionic multilamellar vesicle;-ULV = anionic unilamellar vesicle.
doi:10.1371/journal.pone.0131806.t002
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from the smaller channels within the biofilms[20]. Biofilms have many protective mechanisms
including modified microbial gene expression, altered microenvironment of the bacterial colo-
nies (i.e. pH changes and oxygen deficient zones), the local accumulation of enzymes degrading
antibiotics but the structural complexity and mechanical stability provided by the matrix
undoubtedly restricts drug diffusion and contributes to the antibiotic resistance [21, 29–31].
Our data demonstrated that there was only a limited amount of MLVs diffusing inside biofilms
and that most of the larger liposomes were immobilized at the biofilm surface. It is important
to note that larger liposomes are preferable in regard to their higher drug encapsulation of
Fig 5. Comparison of liposomal distribution in S. aureus and P. aeruginosa biofilms.Comparison of liposomal distribution in both S. aureus and P.
aeruginosa biofilms measured by Liposome Quantity, reflecting the amount of liposomes per unit of biomass in the most intensive section of biofilm, and
Distance, representing how close the majority of liposome approached to the core of biofilm. The histogram displayed medians with ranges, and the
comparison was carried out by Kruskal-Wallis test with Mann-Whitney test for post-hoc. **: P<0.01; NS: no statistic significance, P>0.05; +MLV: cationic
multilamellar vesicle; +ULV: cationic unilamellar vesicle;-MLV: anionic multilamellar vesicle;-ULV: anionic unilamellar vesicle.
doi:10.1371/journal.pone.0131806.g005
Liposomal Formulations against Bacterial Biofilms
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Table 3. Relative viability of S. aureus and P. aeruginosa biofilm at five-minute and 24-hour exposure.
Relative viability (%) at ﬁve-minute exposure Relative viability (%) at 24-hour exposure
+MLV +ULV -MLV -ULV P
value





















































Data are expressed as median and range, n = 8.
All P values are determined with Kruskal-Wallis test.
+MLV = cationic multilamellar vesicle; +ULV = cationic unilamellar vesicle;-MLV = anionic multilamellar vesicle;-ULV = anionic unilamellar vesicle.
doi:10.1371/journal.pone.0131806.t003
Fig 6. Comparison of anti-biofilm effect of liposomes against S. aureus and P. aeruginosa biofilms.Comparison of anti-biofilm effect of liposomes
against both S. aureus and P. aeruginosa biofilms tested by alamarBlue assay. The histogram displayed medians with ranges, and the comparison was
carried out by Kruskal-Wallis test with Mann-Whitney test for post-hoc. *: P<0.05; **: P<0.01, compared to the untreated control; +MLV: cationic
multilamellar vesicle; +ULV: cationic unilamellar vesicle;-MLV: anionic multilamellar vesicle;-ULV: anionic unilamellar vesicle.
doi:10.1371/journal.pone.0131806.g006
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hydrophilic drugs[8, 32]. However, the benefit of an increase in size might be outweighed by a
reduced liposome penetration into biofilms leading to a less effective local drug delivery.
Liposomes with opposite charges but similar sizes were also compared in the distribution
study. The data showed that +MLV adhered better than–MLV to both S. aureus and P. aerugi-
nosa biofilms. Gross et al. proved that for S. aureus, the component with highly negative charge
in the cell wall, teichoic acid, played a key role in the biofilm formation[33, 34]. As for P. aeru-
ginosa, the well-investigated virulence factor, i. e. polyanion exopolysaccharide alginate, is an
important component of its biofilm as well[35, 36]. Consequently, considering these negatively
charged components, the cell surface of these bacteria has overall a moderately negative net
charge[33, 37–40]. Hence it can be hypothesized that repulsive electrostatic forces resulted in
less binding between anionic liposome and biofilm. This makes the cationic liposome promis-
ing in targeted drug delivery for the treatment of bacterial biofilms[18].
In terms of ULVs, the distribution of +ULV and–ULV appeared similar in S. aureus biofilm,
whereas disparate in P. aeruginosa biofilm. It seemed that +ULV not only penetrated into P.
aeruginosa biofilm but also changed the structure of the biofilm by dispersing it. This observa-
tion is potentially important as therapeutic formulations able to compromise the highly orga-
nized ultrastructure of biofilm may render the bacterial cells more susceptible to standard
antibiotics or other agents having similar effects[41]. Our results indicate that the interaction
of liposomes with bacterial biofilms is complex and not simply dictated by the surface charge
or the net charge of the biofilm. This could be partly attributed to the architectural difference
between biofilms formed by different microbes. Based on the patterns in which biofilm was
separated by interstitial voids and water channels, biofilm models were abstracted as stalked or
irregular branching, mushroom-shaped, dense confluent structures and the mixture of the for-
mer[21]. Although direct knowledge of the internal forces and construction of biofilms is lim-
ited, it is possible that after diffusing via interstices and channels into the body of biofilm,
+ULV may disrupt its inner electrostatic equilibrium and collapse the microcolonies that are
not dense or robust enough. However, this requires further investigation.
Since the liposomes used in this study were neither prepared with bactericidal compounds
nor loaded with antimicrobial agents, it is essential to observe their effect on biofilms. If the
liposomes formulated by nontoxic lipid-like molecules showed no nutrient effect on the bacte-
ria, they would be more promising candidates to incorporate bactericidal compounds in a
future study. The influence of liposomes on the growth of biofilm was investigated up to 24
hours. In order to simulate the rapid exposure of topical douching in the sinuses in clinic, a
short exposure of 5 minutes was also tested. The inhibition effect of all four liposomes on bio-
films was confirmed by testing the relative viability of the biofilm. Data demonstrated that
after 24 hours exposure, the biofilm growth was restricted by up to 43% and 75% for S. aureus
and P. aeruginosa respectively. Furthermore, after 24 hours exposure, all the four liposomes
decreased the relative viability of biofilms more than that at the five minute time point, suggest-
ing that S. aureus and P. aeruginosa were not able to grow on exposure to the blank liposomes.
The mechanisms of liposomal toxicity against bacteria remain unclear. Based on data from
studies on other nanoparticles[18, 42, 43], it can be hypothesized that after liposomes attach
and incorporate themselves into the biofilm structure and microbial membrane, they are able
to convert the signaling pathways[16]and disrupt the integrity of the cell membrane. This may
play an important role in inhibiting biofilm growth[44, 45].
Jardeleza et al.[8]reported that blank–ULV showed more pronounced anti-biofilm effect
than–MLV at five-minute exposure. Although the same S. aureus strain and anionic liposomes
were used, our study did not reproduce the same effectivity. The difference on the inhibition
extent between the two researches may be due to different experimental methods, which were
measured by alamarBlue assay and image analysis respectively. The reduction of bacterial
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viability reflected by the restricted metabolic activity of biofilm in our study demonstrated a
similar trend as the biomass decrease observed by Jardeleza et al, although direct comparison
were not possible.
It is also noteworthy to point out that although +ULV displayed the most effective penetra-
tion to P. aeruginosa biofilm, there were no significant differences when comparing the relative
viability after five-minute liposomal treatment with the control. The ongoing viability of the
biofilm with altered structure reflected its refractory nature. Nevertheless, at 24-hour exposure,
+ULV was the most effective formulation to inhibite the P. aeruginosa biofilm. Indeed, the cat-
ionic liposomes lowered the relative viability more than their anionic counterparts, confirming
that the liposomal toxicity against bacteria was correlated with the amount of attached nano-
carriers within a longer incubation time. The observed inhibition of blank liposomes against
both S. aureus and P. aeruginosa biofilms can be expected to enhance their anti-biofilm effec-
tiveness if anti-biofilm drugs are encapsulated in these liposomes.
Further studies are needed to evaluate whether multi-species biofilm growing on nasal
mucosa rather than on glass or plastic surface behave in a similar way as biofilms in in vitro
experiments. It has been reported that in vivo biofilms possess a few structural and component
characteristics that differ from most in vitro biofilms[31, 46]. Whether these differences alter
biofilms’ physicochemical properties that determine their interactions with liposomes remains
unknown. Biofilms found in the nasal sinuses of CRS patients are mixed with the mucus which
can trap nanoparticles by adhesion and/or obstruction[47]. To develop nanoparticles that may
penetrate through this mucus barrier and avoid the natural mucus clearance mechanism will
be the subject of future studies.
Conclusion
This study showed that the charge and size of liposomes influenced their distribution in bio-
films and their intrinsic anti-biofilm effect. Reducing the size of liposomes and formulating
liposomes as positively charged enhanced the penetration and inhibition of S. aureus and P.
aeruginosa biofilms.
Supporting Information
S1 Fig. Influence of liposomes to alamarBlue. This experiment was conducted to confirm the
alamarBlue assay was suitable for the liposomal anti-biofilm study. First, 20μl/well alamarBlue
was added to wells containing 180μl different liposomes (0.9% saline as the control) in a 96
well clear-bottom microplates and incubated at 37°C for one hour. Then the fluorescence
intensity was measured by FLUOstar OPTIMA plate reader (BMG Labtech, Vic, Australia)
equipped with an excitation filter of 520–540 nm and an emission filter of 580–600 nm. This
test for each liposome was carried out in triplicate and the experiments repeated twice. As
result, the fluorescence intensity of alamarBlue treated by +MLV, +ULV,-MLV,-ULV and the
control was 874.0 (871.0–880.0), 881.5 (869.0–903.0), 876.0 (869.0–891.0), 876.5 (870.0–
882.0), and 886.0 (880.0–893.0) respectively, showing there were no statistical differences
between liposomes (Kruskal-Wallis test, P>0.05). Therefore it was concluded that effect of
liposomes to alamarBlue was negligible. +MLV: cationic multilamellar vesicle; +ULV: cationic
unilamellar vesicle;-MLV: anionic multilamellar vesicle;-ULV: anionic unilamellar vesicle.
(TIF)
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